Lilia M. Beauchamp
Lilia M. Beauchamp publishes mostly in Organic Chemistry, Epidemiology and Molecular Biology, on topics such as Cytomegalovirus and herpesvirus research, Herpesvirus Infections and Treatments and Biochemical and Molecular Research.
- World rank
- #2,352,772 of 7,710,434 ranked researchers
- Rank in United States
- #699,791 of 1,627,098
- Works
- 37
- Citations
- 3.9k
- Citations per work
- 104.2
What does Lilia M. Beauchamp research?
Lilia M. Beauchamp's work is mostly in Medicine (36%), Chemistry (32%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1335.5%
- Medicine1335.5%
- Physical Sciences1231.8%
- Chemistry1231.8%
- Life Sciences719.9%
- Everything else512.8%
- 1Organic Chemistry32% of their works
- 2Epidemiology29% of their works
- 3Molecular Biology14% of their works
- 4Infectious Diseases6% of their works
- 5Immunology3% of their works
- 6Pharmaceutical Science3% of their works
Research topics
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
- Biochemical and Molecular Research
- Synthesis and Biological Evaluation
- Synthesis and Reactivity of Heterocycles
- HIV/AIDS drug development and treatment
- Carbohydrate Chemistry and Synthesis
- Quinazolinone synthesis and applications
Which keywords describe Lilia M. Beauchamp's research?
The keywords of their largest research topics: Biological Evaluation, Synthesis, Cytomegalovirus, Infection, Antimicrobial Activity, Herpes Zoster, Herpesviruses and Heterocyclic Compounds.
- Quinazoline
- Indirubin
- Indolizines
- Bioactivity
- Quinoxaline
- Nucleotide Metabolism
- Heterocyclic Compounds
- Herpes Zoster
- Infection
- Synthesis
- Biological Evaluation
- Cytomegalovirus
- Antimicrobial Activity
- Herpesviruses
- Enzyme Regulation
- Derivatives
- Antiretroviral Therapy
- HIV Infection
- Glycosidase Inhibitors
- Oligosaccharide Synthesis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Biological Evaluation183 topics
- Synthesis183 topics
- Cytomegalovirus171 topic
- Infection171 topic
- Antimicrobial Activity142 topics
- Herpes Zoster141 topic
- Herpesviruses141 topic
- Heterocyclic Compounds142 topics
- Enzyme Regulation101 topic
- Nucleotide Metabolism101 topic
- Derivatives81 topic
- Quinoxaline81 topic
- Antiretroviral Therapy61 topic
- Bioactivity61 topic
- HIV Infection61 topic
- Indolizines61 topic
- Glycosidase Inhibitors41 topic
- Indirubin41 topic
- Oligosaccharide Synthesis41 topic
- Quinazoline41 topic
Where does Lilia M. Beauchamp work?
Lilia M. Beauchamp's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does Lilia M. Beauchamp have?
OpenAlex counts 37 works and 3,854 citations for Lilia M. Beauchamp, an h-index of 17, ranking #2,352,772 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lilia M. Beauchamp. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.